Institutionelle bei GENZYME

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Massachusetts Financial Services Co - Other 20,161,134 $553,624,739
Wellington Management Company 19,571,767 $537,440,721
Citigroup Inc. 19,114,176 $524,875,272
Barclays Bank Plc 6,064,677 $166,536,030
FMR Corporation (Fidelity Management & Research Corp) 4,616,283 $126,763,131
Putnam Investment Management, Inc. 4,570,981 $125,519,138
Vanguard Group, Inc. (The) 4,056,983 $111,404,753
Fleetboston Financial Corporation 3,699,293 $101,582,585
Invesco Funds Group, Inc. 3,357,480 $92,196,400
Taunus Corporation 2,931,535 $80,499,951

Topliste der investierten Fonds
Smith Barney Aggressive Growth Fund Inc. 5,500,000 $151,030,000
Vanguard Specialized-Health Care Fund 4,780,940 $131,284,612
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 4,786,524 $131,437,949
MFS Mid Cap Growth Fund 1,972,300 $54,159,358
Massachusetts Investors Growth Stock Fund 1,963,000 $53,903,980
Fidelity Select Portfolios - Biotechnology 1,878,300 $51,578,118
Vanguard Index 500 Fund 1,745,323 $47,926,569
College Retirement Equities Fund-Stock Account 1,620,955 $44,511,424
Eaton Vance Tax-Managed Growth Portfolio 1,616,207 $44,381,044
GCG Trust-Mid Cap Growth Series 1,364,500 $37,469,170